Services Attached to Every Benchling Deal

Benchling sells software that changes how a lab works, so each contract also buys setup labor that moves customer data, configures workflows, and makes the system fit real scientific and regulatory processes. A startup may just need help turning on notebooks and templates, while a big pharma rollout can take 18 months because Benchling has to replace old lab systems, connect records across teams, and validate the product for regulated use.1 2

• Benchling’s product goes beyond a simple note taking tool. Scientists use it for sequence design, experiment records, sample registration, inventory, workflows, and regulated documentation, which raises the amount of setup work needed before a large customer can use the full platform day to day.1
• The company’s revenue mix has shifted toward large biopharma. Top 50 biopharma companies generated 43% of new revenue in 2021, up from 23% in 2019. That pushes average contract value higher, but it also means more data migration, process mapping, and training work gets attached to each win.1 2
• This helps explain why gross margins likely sit below top tier SaaS. Services on every deal make Benchling look less like a pure self serve software product and more like enterprise platforms such as Airtable or other workflow software vendors that use services to drive retention and broader rollout.1 3

Going forward, Benchling’s upside comes from turning long implementations into a wider product footprint inside each account. If it can standardize deployment for regulated labs, services become the wedge that gets Benchling from one research team into company wide R&D infrastructure.1 2